Not much clinical research has been done as far as how and why different galactagogues work — especially herbal galactogogues like fenugreek and blessed thistle.
Not exact matches
Not surprisingly, the spread of diseases (not to mention unhealthy lifestyles that lead to diseases) on a global level is much easier than coordinating care, managing supply chains and clinical trials and rolling out treatmen
Not surprisingly, the spread of diseases (
not to mention unhealthy lifestyles that lead to diseases) on a global level is much easier than coordinating care, managing supply chains and clinical trials and rolling out treatmen
not to mention unhealthy lifestyles that lead to diseases) on a global level is
much easier than coordinating care, managing supply chains and
clinical trials and rolling out treatments.
As one of the world's premier experts in
clinical trials, Don Berry, told me, «The standard
clinical trial is pretty
much the only thing in medicine that hasn't changed in the last 70 years.»
«There's no incentive to reveal
much detail, especially if your product is
not ready for prime time,» said Jerry Yeo, a
clinical chemist and professor at the University of Chicago.
The new Alzheimer's framework may
not be
much of a surprise given numerous, high - profile, late - stage
clinical trial failures in the field by companies like Eli Lilly and Merck, and the decision by other companies (such as Pfizer) to back away from the risk - prone field.
I don't think every pastor who succumbs to abuse of power on a relatively small scale is a
clinical narcissist; and yet I do see very similar behaviour patterns playing out, albeit on a
much smaller scale.
I resonated with
much of the book because I have often walked through seasons of my life that I have called «depression» because I didn't know what else to call it even though I knew it wasn't the
clinical version of this very real disease.
I also doubt that David read
much (or any) of what Matt said in his blog as he missed the point of what Matt was saying — a point I firmly agree with: «Depression is
not just a
clinical condition but also a spiritual condition».
Clinical workers are now discovering that this is
not only predictable but probably
much healthier for the bereaved.
Good point but maybe he expected more from Wilcock but lesson learned i hope tho hes done some good things they did
nt amount to
much where as the mistakes can cost us big time against a more
clinical team.
We need better though but I'm in full 100 % support of the purchase of Shkrodan Mustafi and Lucas Perez.Mustafi can help Koscielny now.I've been saying it here time and time again that it's
not a world clsss striker we have needed but a
clinical finisher which we have lacked for several seasons and counting.Hopefully this guy puts Giroud where he belongs which is on the bench.Though a world class striker is good what we have lacked is someone who puts the game to bed in
clinical fashion but Arsene Wenger has listened to many people to the extent that if he can't get a world class striker then he can get anyone.If Arsenal had a
clinical finisher for some five seasons or so we coulda won the EPL then.Giroud has cost us matches and will continue to cost us matches.Giroud is half decent as someone said here the last time.I expect Perez to be
much better if he can take on his man and be
clinical in front of goal.
Ramsey — overpaid, overused, injury prone,
not clinical enough as a passer or finisher and he's played out of position way too
much to the detriment of our supposed offensive and defensive schemes... obviously I think he has some skills and I'm pleased he didn't let his horrible injury years ago end his career but he holds on to the ball too
much, gives away the ball too often and too cheaply, doesn't play good enough defensively considering the previous concern and often finds himself to far up the pitch way too often for a guy who doesn't score or assist near enough... better suited for Wales where the team is set up to accommodate his and Bales skills
Cazorla looking shite just like all season so far, Sanogo is just a nobody, Ramsey believing his own hype, no pace, we can't counter, no
clinical striker, we lack so
much in our team it's disgraceful.
How I wish we had a
clinical striker like him leading the lines... Even if you have a porous midfield, it helps when you know your dangerman upfront wouldn't miss if given half a chance It makes things so
much easier when you have a
clinical striker
It would either be someone like him, only better and younger (does
nt exist) or someone more
clinical like Ronaldo, to replace him as he's getting older and according to himself — wont be able to score as
much as he does in a couple of years.
We must be cautious, cause even if they don't score
much, they know as a fact tonight they must be
clinical.
I do
nt think it hurts his France chances that
much to stay at Arsenal, as he is
not in French team because he is more
clinical than Mbappe / Dambele / Lacazette, he is there because the team's structure suit him, Griezmann's style of play suits him.
21, out and out striker, a
clinical finisher, a power header, an excellent jumper, definitely one of the future, he's a counter attacking threat (He do
nt have explosive
much pace but he is intelligence when making runs) and he possesses great technique.
No wonder he doesn't see the urgency to do
much (no
clinical finish, no drilling ability like step overs & other fancy skills,
not he best passing & work rate).
This is an incredibly difficult question to answer for a variety of reasons, most importantly because over the years our once vaunted «beautiful» style of play has become a shadow of it's former self, only to be replaced by a less than stellar «plug and play» mentality where players play out of position and adjustments / substitutions are rarely forthcoming before the 75th minute... if you look at our current players, very few would make sense in the traditional Wengerian system... at present, we don't have the personnel to move the ball quickly from deep - lying position, efficient one touch midfielders that can make the necessary through balls or the disciplined and pacey forwards to stretch defences into wide positions, without the aid of the backs coming up into the final 3rd, so that we can attack the defensive lanes in the same
clinical fashion we did years ago... on this current squad, we have only 1 central defender on staf, Mustafi, who seems to have any prowess in the offensive zone or who can even pass two zones through so that we can advance play quickly out of our own end (I have seen some inklings that suggest Holding might have some offensive qualities but too early to tell)... unfortunately Mustafi has a tendency to get himself in trouble when he gets overly aggressive on the ball... from our backs out wide, we've seen pace from the likes of Bellerin and Gibbs and the spirited albeit offensively stunted play of Monreal, but none of these players possess the skill - set required in the offensive zone for the new Wenger scheme which requires deft touches, timely runs to the baseline and consistent crossing, especially when Giroud was playing and his ratio of scored goals per clear chances was relatively low (better last year though)... obviously I like Bellerin's future prospects, as you can't teach pace, but I do worry that he regressed last season, which was obvious to Wenger because there was no way he would have used Ox as the right side wing - back so often knowing that Barcelona could come calling in the off - season, if he thought otherwise... as for our midfielders,
not a single one, minus the more confident Xhaka I watched played for the Swiss national team a couple years ago, who truly makes sense under the traditional Wenger model... Ramsey holds onto the ball too long, gives the ball away cheaply far too often and abandons his defensive responsibilities on a regular basis (doesn't score enough recently to justify): that being said, I've always thought he does possess a little something special, unfortunately he thinks so too... Xhaka is a little too slow to ever boss the midfield and he tends to telegraph his one true strength, his long ball play: although I must admit he did get a bit better during some points in the latter part of last season... it always made me wonder why whenever he played with Coq Wenger always seemed to play Francis in a more advanced role on the pitch... as for Coq, he is way too reckless at the wrong times and has exhibited little offensive prowess yet finds himself in and around the box far too often... let's face it Wenger was ready to throw him in the trash heap when injuries forced him to use Francis and then he had the nerve to act like this was all part of a bigger Wenger constructed plan... he like Ramsey, Xhaka and Elneny don't offer the skills necessary to satisfy the quick transitory nature of our old offensive scheme or the stout defensive mindset needed to protect the defensive zone so that our offensive players can remain aggressive in the final third... on the front end, we have Ozil, a player of immense skill but stunted by his physical demeanor that tends to offend, the fact that he's been played out of position far too many times since arriving and that the players in front of him, minus Sanchez, make little to no sense considering what he has to offer (especially Giroud); just think about the quick counter-attack offence in Real or the space and protection he receives in the German National team's midfield, where teams couldn't afford to focus too heavily on one individual... this player was a passing «specialist» long before he arrived in North London, so only an arrogant or ignorant individual would try to reinvent the wheel and / or
not surround such a talent with the necessary components... in regards to Ox, Walcott and Welbeck, although they all possess serious talents I see them in large part as headless chickens who are on the injury table too
much, lack the necessary first - touch and / or lack the finishing flair to warrant their inclusion in a regular starting eleven; I would say that, of the 3, Ox showed the most upside once we went to a back 3, but even he became a bit too consumed by his pending contract talks before the season ended and that concerned me a bit... if I had to choose one of those 3 players to stay on it would be Ox due to his potential as a plausible alternative to Bellerin in that wing - back position should we continue to use that formation... in Sanchez, we get one of the most committed skill players we've seen on this squad for some years but that could all change soon, if it hasn't already of course... strangely enough, even he doesn't make sense given the constructs of the original Wenger offensive model because he holds onto the ball too long and he will give the ball up a little too often in the offensive zone... a fact that is largely forgotten due to his infectious energy and the fact that the numbers he has achieved seem to justify the means... finally, and in many ways most crucially, Giroud, there is nothing about this team or the offensive system that Wenger has traditionally employed that would even suggest such a player would make sense as a starter... too slow, too inefficient and way too easily dispossessed... once again, I think he has some special skills and, at times, has showed some world - class qualities but he's lack of mobility is an albatross around the necks of our offence... so when you ask who would be our best starting 11, I don't have a clue because of the 5 or 6 players that truly deserve a place in this side, 1 just arrived, 3 aren't under contract beyond 2018 and the other was just sold to Juve... man, this is theraputic because following this team is like an addiction to heroin without the benefits
«Again, I am
not sure Mignolet can do
much better because the strike is so
clinical and goes out before coming back in.
This is an aspect that may
not be
much seen in Walcott, which is why Sanchez would be a better option on the flank to supply an extremely pacy &
clinical walcott.
2) Welbeck is clearly better as a wide man and is
not clinical in the last third: I don't like
much his decision making.
Finally it went for Arsenal, I think first half was very tense, level, nervous, full of tackles, like a bird on a wire, I would say, I agree that Teves caused
much trouble over the right side, I don't know who played there for Arsenal, it looked sometimes as if the Arsenal player had been a bit too slow for Tevez, agree that Fabiansky had a great game, (you always need some fortune for it) and Nasri, he impresses really since some games now,
clinical finishing and one of those who are finishing at all, Faby wasn't at his best and nevertheless he was so important, there were several decisive moments, at the start a save by Fabiansky (and later on some more), the red card, Nasri's goal, after the missed penalty I feared City would take advantage of it, but I think Songs goal broke their mentality, and second half at least the final thirty minutes were rel.
To be honest if he goes I will
not worry that
much we can use the money for a far
clinical finisher tahn him he gives us aerial threat which can be replaced with Bendtner.
And herein lies the primary problem, too
much onus is being placed on a player who — on current evidence — isn't going to be a
clinical finisher.
Picture this — a young, first time mom, prone to
clinical depression and anxiety, trying her very best to be the BEST mom she can possibly be because she loves her baby so very
much... and despite her best efforts and with help, breastfeeding is just
not going well.
... we can run into little obstacles on our way and there are tools available and mostly they are my
clinical skills but occasionally I suggest an epidural or maybe the patient really demands one and I have
not enough to offer that she can do without, yeah of course, interventions need to be used wisely in order to achieve that goal... So I'm open to anything... I use a lot of alternative, I pretty
much use any tool that is available, hopefully in the right situation to achieve that goal.
If a parent observes that there is some sign of impairment due to a nutritional deficit (either because
clinical findings indicate as
much or the parent has tuned in to something lab results won't show), then it would make sense to focus more on the details.
Post-partum stays: How long a woman stays in the hospital after giving birth is
not as important to her wellbeing as how
much support she receives after returning home, according to Karla Nacion, a
clinical assistant professor and coordinator of the nurse - midwifery program at the University of Illinois at Chicago Medical Center.
Let me point to 10 things that I sketched out this morning: too
much money spent on administration and bureaucracy and
not enough on front - line patient care; too little patient - centric information to inform decision making; too little innovation; too little
clinical input into decision making; too
much inertia and hostility to reform, as we have seen today; too
much process - driven target culture distorting
clinical decision making; falling productivity; poor outcomes across a range of
clinical indicators; too often, weak commissioning of servicing; and widening health inequalities in the past 10 years, in addition to the scandals that occurred in Staffordshire and Kent.
I also learned that the seven or eight
clinical papers that I churned out whilst a 100 - hour - a-week
clinical trainee really did
not carry
much scientific weight.
My recall is supposed to be tested later, outside the scanner, but Kuhn and Susan Bookheimer, the
clinical neuropsychologist who is the principal investigator of my brain, have assured me that my recall doesn't matter as
much as the neurological tracks of my memorization.
Since breast cancer treatment in older patients is mostly
not evidence - based due to poor inclusion of older patients in
clinical trials, we propose that studies investigating breast cancer treatment are
much more important than breast cancer screening in this population and should be prioritised.
«What we found is that the group who kept the pain diary — even though we didn't ask them to keep an extensive diary, and even though many of them didn't keep a complete diary — had a
much worse outcome,» says Robert Ferrari, a
clinical professor in the Faculty of Medicine & Dentistry's Department of Medicine and a practicing physician in several Edmonton medical clinics.
Some experts say any treatments should
not be given on a compassionate use basis, but should be part of a carefully conducted
clinical trial, so as to learn as
much about a compound's efficacy as possible.
They «don't provide as
much clarity as the research community would need» to know which projects must follow the new
clinical trial policies, says Heather Pierce, AAMC's senior director for science policy.
While studies have
not shown that too
much CBD can be harmful, products containing either too little or too
much CBD than labeled could negate potential
clinical benefit to patients.
«At the moment, there seems little point in pursuing long - term
clinical goals when there's so
much not known about the technique with human embryos,» says Lovell - Badge.
Researchers are planning to extend the
clinical trial to a
much larger number of patients in a multinational study, to demonstrate
not only a reduced infarct size, but also a reduced mortality in patients who receive early metoprolol during transit to hospital.
Velculescu cautions that medical practice may
not change
much until additional studies validate their findings, and there are ongoing
clinical trials studying the removal of fallopian tubes instead of ovaries in women with cancer - causing, hereditary BRCA1 and BRCA2 mutations.
But recent work shows that while these cancers lack estrogen receptors, progesterone receptors, and aren't driven by the gene HER2, up to a third of these tumors express the androgen receptor —
clinical trials are underway to inhibit the androgen receptor in these tumors in
much the same way that the drug Tamoxifen inhibits estrogen receptor in estrogen - receptor - positive breast cancers.
«The vaccination approach we have employed is
not prophylactic but therapeutic, meaning that immunity was induced after the onset of tumorigenesis — a scenario that resembles the
clinical conditions
much more closely than prophylactic immunization studies, says Anna - Karin Olsson, researcher at the Department of Medical Biochemistry and Microbiology at Uppsala University,» who has led the study.
«This idea didn't really fit with the
clinical experience of the ED physicians at Mayo Clinic, but there wasn't
much information out there to know what's going on nationally.»
Of course
not all of these seminars proved worth sacrificing valuable lab - time for, and whilst most of the speakers were very professional one notable exception spent
much of his talk describing the
clinical depression his previous job had caused!
This trial holds
much promise
not only for those with spinal cord injuries, but for other hESC - based therapies that may now have a better chance at receiving FDA - approval for
clinical trials.
«In
clinical trials, therapies with antioxidants have been pretty
much a bust, and it's
not entirely clear why,» he says.
Although this possibility has
not yet attracted as
much attention as the ideas of cell replacement, personalized medicine and other more direct
clinical applications, hESCs are expected to be superior to most commonly used cell - culture models of drug discovery which employ tumor - derived or immortalized cell lines or primary cell culture.
«There's really
not much scientific studies on the use of kukui oil in the dermatologic literature, and the one study I know of failed to demonstrate any differences between kukui oil and the placebo in treating mild psoriasis,» says Julia Tzu, MD,
clinical assistant professor of dermatology at New York University School of Medicine.
According to Dr. Daniel A. Leffler, director of
clinical research at the Celiac Center at Beth Israel Deaconess Medical Center in Boston, the idea that people going gluten - free to lose weight, boost energy or generally feel healthier doesn't make
much sense.